Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Consequences of Changing Current Standards: Endocrine Status After Routine Fallopian Tube Removal

NCT02669498 is registered in ClinicalTrials.gov with Insel Gruppe AG, University Hospital Bern as lead sponsor.

NCT NCT02669498
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02669498 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Consequences of Changing Current Standards: Endocrine Status After Routine Fallopian Tube Removal
Lead sponsor
Insel Gruppe AG, University Hospital Bern
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2013
Completion date
December 1, 2021
Enrollment
128 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

pelvic surgery, routine fallopian tube removal